Sponsor pipeline

Hanmi Pharmaceutical Company Limited clinical trial pipeline

Get alerts when Hanmi Pharmaceutical Company Limited's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
5
Phase 2
5
Phase 3
2
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07379333 A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes… Type 2 Diabetes Recruiting 2026-05-13
NCT07660796 A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential… Hypertension Not Yet Recruiting 2026-06-30
Phase 2
NCT07527650 Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus Recruiting 2026-08-17
NCT04775706 Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF… Short Bowel Syndrome Recruiting 2026-08-12
NCT07449754 Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or… Advanced or Metastatic Melanoma Recruiting 2026-03-04
NCT04732416 HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital… Congenital Hyperinsulinism Active, Not Recruiting 2026-08-26
NCT07205900 Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus Obese Active, Not Recruiting 2026-04-08
Phase 1
NCT06234397 Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or… Advanced or Metastatic Solid Tumors Recruiting 2026-09-25
NCT07219589 A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants Obesity Recruiting 2026-05-04
NCT06724016 Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or… Advanced or Metastatic Solid Tumors Recruiting 2025-12-17
NCT05598151 Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors Active, Not Recruiting 2026-08-12
NCT07297693 A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in… Healthy Not Yet Recruiting 2025-12-22
Not specified
NCT07784296 Effectiveness and Safety of Sequential Triple Combination Therapy… Hypertension Recruiting 2026-08-25

Disease areas by active trials

Diabetes (2) · Hypertension (2) · Obesity (2) · Type 2 Diabetes (2) · Melanoma (1)

Get alerts when Hanmi Pharmaceutical Company Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free